Search Results - "Heldwein, Matthias"

Redefining the role of surgery in early small-cell lung cancer by Doerr, Fabian, Stange, Sebastian, Michel, Maximilian, Schlachtenberger, Georg, Menghesha, Hruy, Wahlers, Thorsten, Hekmat, Khosro, Heldwein, Matthias B.

“…Purpose Resection is guideline recommended in stage I small-cell lung cancer (SCLC) but not in stage II. In this stage, patients are treated with a…”
Get full text

Pulmonary metastasectomy for metastatic head and neck cancer prolongs survival significantly compared to non-surgical therapy by Schlachtenberger, Georg, Doerr, Fabian, Menghesha, Hruy, Heldwein, Matthias B, Lauinger, Patrick, Wolber, Philipp, Klussmann, Jens Peter, Wahlers, Thorsten, Hekmat, Khosro

“…Abstract OBJECTIVES Pulmonary metastasectomy (PM) is an established procedure for selected patients with metastatic head and neck cancer (HNC). Non-surgical…”
Get full text

New experimental model of hind limb ischemia in pot-bellied pigs by Samatoshenkov, Igor, Krasivskyi, Ihor, Djordjevic, Ilija, Ivanov, Borko, Merkle, Julia, Sakhibgareeva, Alina, Aimaletdinov, Alexander, Samatoshenkova, Julia, Shakurova, Ilvira, Kadyrov, Marat, Sabashnikov, Anton, Heldwein, Matthias B.

“…The simulation of limb ischemia in large laboratory animals is a complex and currently topical task in experimental medicine. Meanwhile, there is a demand for…”
Get full text

Adjuvant chemotherapy for locally advanced non-small cell lung cancer: still state of the art or an outdated therapy? by Schlachtenberger, Georg, Hekmat, Khosro, Wahlers, Thorsten, Heldwein, Matthias B.

Get full text

Prognostic impact of lymph node spreading pattern in N2 NSCLC patients by Schlachtenberger, Georg, Doerr, Fabian, Menghesha, Hruy, Amorin, Andres, Hoepker, Katja, Hagmeyer, Lars, Wahlers, Thorsten, Hekmat, Khosro, Heldwein, Matthias B.

“…One-third of non-small cell lung cancer (NSCLC) patients are diagnosed with locally advanced disease. Long-term survival in stage IIIA/B-N2 remains poor; this…”
Get full text

Sublobar resection without staging and lymphadenectomy for ≤2 cm Non-Small Cell Lung Cancer is no adequate therapy by Schlachtenberger, Georg, Doerr, Fabian, Menghesha, Hruy, Hagmeyer, Lars, Bennink, Gerardus, Gaisendrees, Christopher, Wahlers, Thorsten, Hekmat, Khosro, Heldwein, Matthias B.

“…ObjectiveSublobar resection is frequently performed for Non-Small Cell Lung Cancer (NSCLC) patients with ≤2 cm nodules. Frequently, both proper staging and…”
Get full text

Drop Metastasis of Type B Thymoma 5 Years After Resection by Heldwein, Matthias B, Doerr, Fabian, Hekmat, Khosro

Get full text

Do skip-N2 metastases significantly impact overall survival and disease-free interval in N2 non-small-cell lung cancer patients? A multicentre analysis by Schlachtenberger, Georg, Schallenberg, Simon, Doerr, Fabian, Menghesha, Hruy, Gaisendrees, Christopher, Amorin, Andres, Grathwohl, Corinna, Büttner, Reinhard, Quaas, Alexander, Horst, David, Klauschen, Frederick, Frost, Nikolaj, Rueckert, Jens-C, Neudecker, Jens, Höpker, Katja, Wahlers, Thorsten, Hekmat, Khosro, Heldwein, Matthias B

“…Abstract OBJECTIVES Skip-N2 metastasis (N0N2), thus N2 metastasis in the absence of N1 metastasis, occurs in ∼20–30% of non-small-cell lung cancer patients…”
Get full text

Stage I and II Small-Cell Lung Cancer—New Challenge for Surgery by Doerr, Fabian, Stange, Sebastian, Michel, Maximilian, Schlachtenberger, Georg, Menghesha, Hruy, Wahlers, Thorsten, Hekmat, Khosro, Heldwein, Matthias B.

“…Purpose The recommended treatment for small-cell lung cancer (SCLC) currently is surgery in stage I disease. We wondered about stage II SCLC and present a…”
Get full text

Postoperative long-term survival of non-small cell lung cancer patients with skip-N2 metastases by Schlachtenberger, Georg, Doerr, Fabian, Menghesha, Hruy, Heldwein, Matthias B., Hagmeyer, Lars, Michel, Maximilian, Schaefer, Stephan C., Wahlers, Thorsten, Hekmat, Khosro

“…Radical lymphadenectomy is crucial in operations for non-small cell lung cancer (NSCLC). Usually pN1 and pN2 lymph nodes are affected consecutively (N1N2)…”
Get full text

Different pulmonary adenocarcinoma growth patterns significantly affect survival by Heldwein, Matthias B., Schlachtenberger, Georg, Doerr, Fabian, Menghesha, Hruy, Bennink, Gerardus, Schroeder, Karl-Moritz, Schaefer, Stephan C., Wahlers, Thorsten, Hekmat, Khosro

“…Adenocarcinoma (AC) is the number one pathological entity of lung cancer with approximately 30–40% of cases. It is known to be heterogeneous and has 5…”
Get full text

A comparative study of four thoracic mortality scores by Schlachtenberger, Georg, Doerr, Fabian, Menghesha, Hruy, Amorin, Andres, Gaisendrees, Christopher, Miesen, Sebastian, Seibel, Christian, Wahlers, Thorsten, Hekmat, Khosro, Heldwein, Matthias B.

“…Background The percentage of patients in resectable stages at initial diagnosis of non-small cell lung cancer (NSCLC) raises due to better screening programs…”
Get full text

Perigraft reaction and incorporation of porcine and bovine pericardial patches by Schlachtenberger, Georg, Doerr, Fabian, Brezina, Annamaria, Menghesha, Hruy, Heldwein, Matthias B, Bennink, Gerardus, Menger, Michael D, Moussavian, Mohammed, Hekmat, Khosro, Wahlers, Thorsten

“…Bovine and porcine pericardial patches are frequently used in cardiothoracic and vascular surgery. There are no guidelines recommending the usage of these…”
Get full text

Closing the RCT Gap-A Large Meta-Analysis on the Role of Surgery in Stage I-III Small Cell Lung Cancer Patients by Doerr, Fabian, Stange, Sebastian, Salamon, Sophie, Grapatsas, Konstantinos, Baldes, Natalie, Michel, Maximilian, Menghesha, Hruy, Schlachtenberger, Georg, Heldwein, Matthias B, Hagmeyer, Lars, Wolf, Jürgen, Roessner, Eric D, Wahlers, Thorsten, Schuler, Martin, Hekmat, Khosro, Bölükbas, Servet

“…Despite clear guideline recommendations, surgery is not consistently carried out as part of multimodal therapy in stage I small cell lung cancer (SCLC)…”
Get full text

Cancer-specific immune evasion and substantial heterogeneity within cancer types provide evidence for personalized immunotherapy by Thelen, Martin, Wennhold, Kerstin, Lehmann, Jonas, Garcia-Marquez, Maria, Klein, Sebastian, Kochen, Elena, Lohneis, Philipp, Lechner, Axel, Wagener-Ryczek, Svenja, Plum, Patrick Sven, Velazquez Camacho, Oscar, Pfister, David, Dörr, Fabian, Heldwein, Matthias, Hekmat, Khosro, Beutner, Dirk, Klussmann, Jens Peter, Thangarajah, Fabinshy, Ratiu, Dominik, Malter, Wolfram, Merkelbach-Bruse, Sabine, Bruns, Christiane Josephine, Quaas, Alexander, von Bergwelt-Baildon, Michael, Schlößer, Hans A.

“…The immune response against cancer is orchestrated by various parameters and site-dependent specificities have been poorly investigated. In our analyses of ten…”
Get full text

Lymphangiosis carcinomatosa independently affects long-term survival of Non-Small Cell Lung Cancer patients by Heldwein, Matthias B., Doerr, Fabian, Schlachtenberger, Georg, Menghesha, Hruy, Kuhn, Elmar W., Scheel, Andreas H., Michel, Maximilian, Wahlers, Thorsten, Hekmat, Khosro

“…The significance of postoperatively diagnosed Lymphangiosis Carcinomatosa (L1) as an independent risk factor for long-term survival in Non-Small Cell Lung…”
Get full text

Postoperative Tobacco Cessation Improves Quality of Life, Lung Function and Long-Term Survival in Non-Small-Cell Lung Cancer Patients by Doerr, Fabian, Leschczyk, Tobias, Grapatsas, Konstantinos, Menghesha, Hruy, Baldes, Natalie, Schlachtenberger, Georg, Heldwein, Matthias B, Michel, Maximilian, Quaas, Alexander, Hagmeyer, Lars, Höpker, Katja, Wahlers, Thorsten, Darwiche, Kaid, Taube, Christian, Schuler, Martin, Hekmat, Khosro, Bölükbas, Servet

“…About 90% of all non-small cell lung cancer (NSCLC) cases are associated with inhalative tabacco smoking. Half of patients continue smoking during lung cancer…”
Get full text

A comparative study of four intensive care outcome prediction models in cardiac surgery patients by Doerr, Fabian, Badreldin, Akmal Ma, Heldwein, Matthias B, Bossert, Torsten, Richter, Markus, Lehmann, Thomas, Bayer, Ole, Hekmat, Khosro

“…Outcome prediction scoring systems are increasingly used in intensive care medicine, but most were not developed for use in cardiac surgery patients. We…”
Get full text

The impact of thymectomy in subgroups of Myasthenia gravis patients: a single center longitudinal observation by Menghesha, Hruy, Schroeter, Michael, Nelke, Christopher, Ruck, Tobias, Schlachtenberger, Georg, Welskop, Clara, Camo, Amina, Heldwein, Matthias, Bennink, Gerardus, Wahlers, Thorsten, Bölükbas, Servet, Doerr, Fabian, Hekmat, Khosro

“…Myasthenia gravis (MG) is a rare neuromuscular disorder. Symptoms can range from ptosis only to life threatening myasthenic crisis. Thymectomy is recommended…”
Get full text

Neoadjuvant chemoimmunotherapy as a potential therapeutic option in NSCLC UICC stage IIIA with multilevel N2 disease by Menghesha, Hruy, Doerr, Fabian, Schlachtenberger, Georg, Estremadoyro, Andres Amorin, Töpelt, Karin, Wahlers, Thorsten, Hekmat, Khosro, Heldwein, Matthias

“…Lung Cancer is still one of the leading causes for cancer related death worldwide. The determination of an adequate therapeutic approach requests a precise…”
Get full text